Moreover, inflammation‐driven modulation of key neurotrophic factors such as BDNF, VEGF, and GluN2B has been recognized as an essential component of depression pathophysiology and a crucial target for effective treatment [3, 4]. This evidence concerns the gene VEGFA and depressive symptom measurement.